NavDx®
Patients
Physicians
News
Careers
About
- Team
Contact

Philip Haydon, PhD

Search for:

Recent News

Virtual Booth

September 28, 2021

Natick company develops test to detect head and neck cancer that could lead to earlier diagnosis

August 4, 2021

New Saliva Test Detects Head and Neck Cancer

June 24, 2021

Naveris, Inc. Raises $19 Million in Financing to Advance and Commercialize Blood Tests for Early Detection of HPV and Other Viral-Related Cancers

December 15, 2020

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

March 26, 2020

Blood Test Accurately Identifies HPV-related Head and Neck Cancer Recurrence; Prospective Clinical Study Published in Journal of Clinical Oncology

February 5, 2020

Study finds blood test accurately tracks HPV-linked head and neck cancer

February 4, 2020

Researchers identify traits linked to better outcomes in HPV-linked head and neck cancer

June 14, 2019

Biomarker blood test accurately confirms remission in patients with HPV-associated oral cancer

October 28, 2018

HEALIO–Liquid biopsy test confirms remission in HPV-associated oral cancer

October 28, 2018

Publications

Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer (Journal of Clinical Oncology, 2020)

Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer (Clinical Cancer Research 2019)

Contact

22 Strathmore Road
Natick, MA 01760

(833)-NAVERIS/ (833)-628-3747

contact@naveris.com

Search

Search for:

Follow us on:

NavDx®
Patients
Physicians
News
Careers
About
- Team
Contact

© 2021 Naveris Inc., All rights reserved
Privacy Policy | Notice of Privacy Practices Under HIPAA

NavDx®
Patients
Physicians
News
Careers
About
- Team
Contact